Keywords :
Adrenergic beta-Antagonists/therapeutic use; Antiparkinson Agents/therapeutic use; Benzodiazepines/therapeutic use; Cholinergic Antagonists/therapeutic use; Dopamine Agonists/therapeutic use; Drug Therapy, Combination; Dyskinesias/drug therapy; Early Diagnosis; Humans; Levodopa/therapeutic use; Male; Middle Aged; Neuroprotective Agents/therapeutic use; Parkinson Disease/diagnosis/drug therapy; Prognosis; Quality of Life; Treatment Outcome
Scopus citations®
without self-citations
0